Roper Technologies (NYSE: ROP) reported Q3 EPS of $3.17, $0.13 better than the analyst estimate of $3.04. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.35 billion.

"We are very pleased with the continued strong execution by our business leaders this quarter," said Neil Hunn, Roper’s President and CEO. "We once again benefited from our diverse and resilient portfolio, and saw improvement across many businesses. Importantly, we have seen an accelerated shift towards SaaS solutions and an expansion of our software networks. Notably, our laboratory software businesses and Verathon’s video intubation solutions have been on the front lines of the battle against COVID-19.”

"We successfully deployed $5.8 billion over the past few months, led by our acquisition of Vertafore last month. These niche software acquisitions continue Roper’s long-term transformation by enhancing the quality and resilience of our portfolio, increasing our mix of recurring revenue, and further strengthening our ability to consistently compound cash flow. We are well positioned for a strong fourth quarter and a great 2021," concluded Mr. Hunn.

GUIDANCE:

Roper Technologies sees Q4 2020 EPS of $3.39-$3.49, versus the consensus of $3.50.

Roper Technologies sees FY2020 EPS of $12.55-$12.65, versus the consensus of $12.49.

• The Company now expects full year adjusted DEPS of $12.55 - $12.65, compared to previous guidance of $11.90 - $12.40.
• For the fourth quarter of 2020, the Company expects adjusted DEPS of $3.39 - $3.49.
• The Company’s guidance excludes the impact of unannounced future acquisitions or divestitures

For earnings history and earnings-related data on Roper Technologies (ROP) click here.